Xeris Biopharma Holdings (XERS) Interest Coverage Ratio (2020 - 2026)
Xeris Biopharma Holdings' (XERS) quarterly Interest Coverage Ratio came in at 0.92 in Q1 2026, up 356.18% YoY from 0.2 in Q1 2025, and down 60.68% on a QoQ basis from 2.33 in Q4 2025.
Xeris Biopharma Holdings (XERS) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Xeris Biopharma Holdings (XERS) has 7 years of Interest Coverage Ratio data on file, last reported at 0.92 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 356.18% year-over-year to 0.92 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.15 (up 259.63% YoY) and the FY2025 annual result came in at 0.58, up 441.03% from the prior year.
- Interest Coverage Ratio eased to 0.92 in Q1 2026, from 2.33 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 2.33 in Q4 2025 to a low of 4.79 in Q4 2022.
- A 5-year average of 0.86 and a median of 0.95 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio sank 660.24% — and 2025, when it soared 735.68%.
- Tracing XERS's Interest Coverage Ratio over 5 years: stood at 4.79 in 2022, then soared by 70.7% to 1.4 in 2023, then jumped by 119.88% to 0.28 in 2024, then surged by 735.68% to 2.33 in 2025, then tumbled by 60.68% to 0.92 in 2026.
- The last three Interest Coverage Ratio figures came in at 0.92 (Q1 2026), 2.33 (Q4 2025), and 0.78 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Xeris Biopharma Holdings | 1.48 Bn | 1.36 Bn | 79.59 Mn | 0.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.08 |
| Mar 31, 2026 | 0.92 |
| Dec 31, 2025 | 2.33 |
| Sep 30, 2025 | 0.78 |
| Jun 30, 2025 | 0.15 |
| Mar 31, 2025 | -0.36 |
| Dec 31, 2024 | 0.28 |
| Sep 30, 2024 | -1.49 |
| Jun 30, 2024 | -0.95 |
| Mar 31, 2024 | -1.65 |
| Dec 31, 2023 | -1.40 |
| Sep 30, 2023 | -0.57 |
| Jun 30, 2023 | -1.85 |
| Mar 31, 2023 | -1.35 |
| Dec 31, 2022 | -4.79 |
| Sep 30, 2022 | -1.82 |
| Jun 30, 2022 | -0.24 |
| Mar 31, 2022 | -2.68 |
| Dec 31, 2021 | -26.58 |
| Sep 30, 2021 | -13.53 |